Essa制药 EPIX 深 沪
已收盘 10-09 16:00:00 美东时间
0.2012
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 0.2012
- 总市值 951.85万
- 52周最高 4.419
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 -0.291
- 委 比 0.00%
- 总股本 4730.84万
- 历史最高 243.309
- 量 比 0
- 振 幅 0.00%
- 历史最低 -0.291
- 每 手 1
- 风险率 0.18%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多ESSA Announces Completion of Arrangement with XenoTherapeutics
SOUTH SAN FRANCISCO, Calif., USA and VANCOUVER, BC, Canada, Oct. 9, 2025 /PRNewswire/ - ESSA Pharma Inc. (NASDAQ: EPIX) ("ESSA" or the "Company") today announced the completion of XenoTherap...
10-09 19:00
ESSA Securityholders Approve Acquisition by XenoTherapeutics
SOUTH SAN FRANCISCO, USA and VANCOUVER, Canada, Oct. 6, 2025 /PRNewswire/ - ESSA Pharma Inc. (NASDAQ: EPIX) ("ESSA" or the "Company") is pleased to announce that its Securityholders (as defi...
10-07 05:14
ESSA Pharma Faces Class Action Lawsuit in California
The latest update is out from ESSA Pharma ( ($EPIX) ). On September 30, 2025, a...
10-03 18:28
ESSA Pharma cuts shareholder payout in revised Xeno deal
ESSA Pharma (NASDAQ:EPIX) fell above 18% premarket on Wednesday after the company revised terms of its merger with biotech firm XenoTherapeutics, lowering expected shareholder payout due to potential ...
09-24 18:35
ESSA Pharma Amends Agreement With XenoTherapeutics, Shareholders To Receive $0.12 Cash And Up To $0.14 Per CVR
Shareholders expected to receive approximately $0.12 per share in cash upon closing of transaction and up to approximately $0.14 per CVR under revised termsFurther Adjourns Special Meeting to October 3, 2025
09-24 18:07
ESSA Pharma Inc. Amends Agreement with XenoTherapeutics
Shareholders expected to receive approximately $0.12 per share in cash upon closing of transaction and up to approximately $0.14 per CVR under revised terms Further Adjourns Special Meeting ...
09-24 18:00
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Invivyd (NASDAQ:IVVD) stock increased by 132.3% to $1.3 during Tuesday...
08-26 20:09
ESSA Pharma Confirms $80M Capital Distribution Paid August 22; Shares Began Trading Ex-Dividend August 25 After Correcting Due Bill Period
ESSA Pharma Inc. ("ESSA," or the "Company") (NASDAQ:EPIX) announced on August 14, 2025 that, in connection with the Company's previously announced return of capital distribution in the aggregate amount of US$80,000,000
08-26 04:26
ESSA Pharma Q3 EPS $(0.09) Beats $(0.16) Estimate
ESSA Pharma (NASDAQ:EPIX) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.16) by 43.75 percent. This is a 43.75 percent increase over losses of $(0.16) per share from the
08-13 21:12
ESSA Pharma To Distribute $80M To Shareholders
SOUTH SAN FRANCISCO, Calif and VANCOUVER, Canada, Aug. 6, 2025 /PRNewswire/ -- ESSA Pharma Inc. ("ESSA," or the "Company") (NASDAQ:EPIX) today announced that, following the Company's receipt of an order from the Supreme
08-07 05:22
